Lucknow Speciality Pharma

Obinutuzumab Injection 1000 mg
Obinutuzumab injection is used with chlorambucil (Leukeran) to treat chronic lymphocytic leukemia (CLL; a type of cancer of the white blood cells). To get access, please contact Patient Support Team @ +91 9760014849 / 9555306364 / 9794360370 / 9140551027, Time 9 am - 8 pm IST or send us a request on email (urgent@lucknowpharma.com) / WhatsApp for the same.
Get Access Price
WhatsApp

Obinutuzumab Injection was approved for medical use in the United States in 2017. It is on the World Health Organization’s List of Essential Medicines.

Obinutuzumab Injection Available Price In Lucknow Banaras Nepal

Obinutuzumab Injection

  • API – Obinutuzumab
  • Packaging – Glass Bottle
  • Strength – 1000 mg
  • Brand name Available – Gazyva

What is Obinutuzumab Injection used for?

Obinutuzumab Injection is used with chlorambucil (Leukeran) to treat chronic lymphocytic leukemia (CLL; a type of cancer of the white blood cells).

    About Us

    Lucknow Speciality Pharma is dedicated to delivering life-changing healthcare solutions. As a trusted wholesale supplier of specialized medicines, we cater to critical care areas such as oncology, nephrology, and rare diseases. Our patient-centric approach also includes personalized catering services, ensuring that patients receive the care, support, and nutrition they need to thrive. We also extend our services globally, welcoming international patients and buyers who seek our expertise and high-quality products.

    Lucknow Speciality Pharma is a registered Pharmaceutical Firm in Lucknow, India. Registered under GST Act. Registration Number : 09AAOPG3102HIZY. It provide assistance and connectivity with drug pharmacies or distributors for access to genuine medicines at competitive prices. 

    Get Access To Obinutuzumab Injection 1000 mg

    Enter Buying Requirements Details

    For precise quotations, kindly ensure your requirements include the product name, order quantity, intended usage, and any special requests you may have.

    Branch Offices in India : Lucknow | Agra | Varanasi | Gorakhpur | Kanpur | Indore | Patna | Kolkata | Nepal

    FAQs – Medicine Questions

    Obinutuzumab Injection 1000 mg
    How long does obinutuzumab infusion take?
    Administer at 25 mg/hr over 4 hours. Do not increase the infusion rate.
    Is obinutuzumab a chemotherapy?
    Obinutuzumab is an anti-cancer (“antineoplastic” or “cytotoxic”) chemotherapy drug. Obinutuzumab is classified as a “monoclonal antibody” (For more detail, see “How Obinutuzumab Works” section below).
    How often is obinutuzumab given?
    GAZYVA is given for a total of 6 cycles, or rounds of treatment. Each cycle will last 28 days. Treatment occurs only on certain days of each cycle and that is usually followed by several weeks of rest and recovery. This means that most people will complete their GAZYVA treatment in about 6 months.
    Where can I buy Obinutuzumab Injection?

    You can buy Obinutuzumab Injection from any authorized whole-seller after getting a prescription from a qualified doctor. It is always better to check the credential of the whole-seller/supplier/exporter before buying the product.

    The buyer should check the existing law in their home country before importing the product.

    What is the procedure to buy Obinutuzumab Injection?

    Patients can simply fill the order form or can send mail at info@lucknowpharma.com Patients can also send WhatsApp messages to +91-9555306364 We will reply ASAP with the details of the Obinutuzumab Injection price as well as procurement procedure.

    Note:- The order will be confirmed only after the receipt of the Valid prescription of the Clinician.

    Is obinutuzumab safe?
    Patients without or with prior treatment in the obinutuzumab plus FC arm demonstrated the highest 4-year overall survival at 94% and 70%, respectively, followed by 85% and 68% in the obinutuzumab plus bendamustine arm, 83% and 59% in the monotherapy arm, and 67% and 54% in the obinutuzumab plus chlorambucil arm.

    NEWS / UPDATES

    1. Roche Products Limited, Electronic medicines compendium (emc), [Revised on Jan 2021] [ Accessed on 11th August 2021], https://www.medicines.org.uk/emc/files/pil.3279.pdf
    2. Genentech, Inc, US Food and Drug Administration, [Revised on Nov 2017] [ Accessed on 9th August 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125486s017s018lbl.pdf
    3. Jenny O’Nions, William Townsend et al; The role of obinutuzumab in the management of follicular lymphoma; Future Oncology; Published on Nov 2019; Accessed on 11/08/2021; https://pubmed.ncbi.nlm.nih.gov/31538821/